A Systematic Review and Meta-analysis of the Association Between Sarcopenia and Myocardial Infarction
Overview
Affiliations
Background: Systematic review and meta-analysis of the association between sarcopenia and the development of myocardial infarction.
Methods: PubMed, Cochrane Library, and Embase were searched for studies on the association between sarcopenia and myocardial infarction from their inception until November 26, 2022. The fixed-effects model was used to calculate the combined risk ratio (RR) of sarcopenia in patients with myocardial infarction. Sensitivity analysis was used to test the robust of the combined result, and funnel plot were used to test publication bias.
Results: Five studies were included finally. There was no significant association between sarcopenia and risk of developing myocardial infarction [RR = 1.01; 95% CI = 0.94, 1.08; P = 0.317]. The sensitivity analysis showed robust of the combined result. The funnel plot showed no significant publication bias.
Conclusion: Limited evidence suggests no definitive association between sarcopenia and risk of myocardial infarction.
A sarcopenia prediction model based on the calf maximum muscle circumference measured by ultrasound.
Wei A, Zou Y, Tang Z, Guo F, Zhou Y BMC Geriatr. 2025; 25(1):81.
PMID: 39910436 PMC: 11796220. DOI: 10.1186/s12877-025-05733-y.
Sarcopenia and Cardiogeriatrics: The Links Between Skeletal Muscle Decline and Cardiovascular Aging.
Anagnostou D, Theodorakis N, Hitas C, Kreouzi M, Pantos I, Vamvakou G Nutrients. 2025; 17(2).
PMID: 39861412 PMC: 11767851. DOI: 10.3390/nu17020282.
Hayat U, Kamal F, Kamal M, Mirza W, Ahmad T, Gangwani M J Clin Med. 2024; 13(22).
PMID: 39598090 PMC: 11595205. DOI: 10.3390/jcm13226946.